About
CBC Health will always be at the forefront of regenerative health science, as CBCG is directly involved in pushing the envelope for regenerative health by supporting regenerative clinical research. Since 2012, CBCG has conducted or participated in research projects and clinical trials aimed to help people find therapies for diseases that have no cure today, like the treatment of cerebral palsy and ischemic stroke. CBCG has also participated in clinical studies at leading medical institutions like Duke University Hospital, USA.
In 2018, CBC Health began the process to open a new medical facility in Munich, Germany, known as CBCHealth Med Munich, which will focus on providing cord blood treatments for patients suffering from Ischemic Stroke. If you are interested in learning more about the Munich location, please visit cbchealth.ch
CBC Health will always be at the forefront of regenerative health science, as CBCG is directly involved in pushing the envelope for regenerative health by supporting regenerative clinical research. Since 2012, CBCG has conducted or participated in research projects and clinical trials aimed to help people find therapies for diseases that have no cure today, like the treatment of cerebral palsy and ischemic stroke. CBCG has also participated in clinical studies at leading medical institutions like Duke University Hospital, USA.
In 2018, CBC Health began the process to open a new medical facility in Munich, Germany, known as CBCHealth Med Munich, which will focus on providing cord blood treatments for patients suffering from Ischemic Stroke. If you are interested in learning more about the Munich location, please visit cbchealth.ch